The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The novel formulation of rizatriptan and meloxicam (Symbravo, Axome Therapeutics) is for the acute treatment of migraine with ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in veterinary medicine to manage pain, inflammation, and fever in various animal species. Understanding the pharmacokinetics (PK ...

Maternal age and NSAID use during the preconception period were associated with a longer time to pregnancy among women with SpA.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

A recent study conducted by the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) found that mislabeled NSAID ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...